N Y Lycke - JoVE Visualize

Showing results (11-20 of 18) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 18 results.

Journal of Immunology (Baltimore, Md. : 1950)|October 15, 1990

T lymphocytes that express CD4 and the alpha beta-T cell receptor but lack Thy-1. Preferential localization in Peyer's patchesG R Harriman, N Y Lycke, L J Elwood, et al.

Journal of Immunology (Baltimore, Md. : 1950)|February 11, 1999

Adjuvanticity of the cholera toxin A1-based gene fusion protein, CTA1-DD, is critically dependent on the ADP-ribosyltransferase and Ig-binding activityL C Agren, L Ekman, B Löwenadler, et al.

Immunology|November 26, 1997

Interferon-gamma receptor-deficient mice exhibit impaired gut mucosal immune responses but intact oral toleranceM Kjerrulf, D Grdic, L Ekman, et al.

Journal of Immunology (Baltimore, Md. : 1950)|September 15, 1995

Paradoxical IgA immunity in CD4-deficient mice. Lack of cholera toxin-specific protective immunity despite normal gut mucosal IgA differentiationC E Hörnquist, L Ekman, K D Grdic, et al.

Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1996

IL-6-deficient mice exhibit normal mucosal IgA responses to local immunizations and Helicobacter felis infectionA K Bromander, L Ekman, M Kopf, et al.

Mucosal Immunology|November 27, 2014

Cholera toxin adjuvant promotes a balanced Th1/Th2/Th17 response independently of IL-12 and IL-17 by acting on Gsα in CD11b⁺ DCsJ Mattsson, K Schön, L Ekman, et al.

Mucosal Immunology|July 13, 2012

Re-utilization of germinal centers in multiple Peyer's patches results in highly synchronized, oligoclonal, and affinity-matured gut IgA responsesP Bergqvist, A Stensson, L Hazanov, et al.

Mucosal Immunology|April 9, 2010

Gene expression profiling identifies STAT3 as a novel pathway for immunomodulation by cholera toxin adjuvantA Sjöblom-Hallén, U Marklund, A Nerstedt, et al.

Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 18 results.

Journal of Immunology (Baltimore, Md. : 1950)|October 15, 1990

T lymphocytes that express CD4 and the alpha beta-T cell receptor but lack Thy-1. Preferential localization in Peyer's patchesG R Harriman, N Y Lycke, L J Elwood, et al.

Journal of Immunology (Baltimore, Md. : 1950)|February 11, 1999

Adjuvanticity of the cholera toxin A1-based gene fusion protein, CTA1-DD, is critically dependent on the ADP-ribosyltransferase and Ig-binding activityL C Agren, L Ekman, B Löwenadler, et al.

Immunology|November 26, 1997

Interferon-gamma receptor-deficient mice exhibit impaired gut mucosal immune responses but intact oral toleranceM Kjerrulf, D Grdic, L Ekman, et al.

Journal of Immunology (Baltimore, Md. : 1950)|September 15, 1995

Paradoxical IgA immunity in CD4-deficient mice. Lack of cholera toxin-specific protective immunity despite normal gut mucosal IgA differentiationC E Hörnquist, L Ekman, K D Grdic, et al.

Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1996

IL-6-deficient mice exhibit normal mucosal IgA responses to local immunizations and Helicobacter felis infectionA K Bromander, L Ekman, M Kopf, et al.

Mucosal Immunology|November 27, 2014

Cholera toxin adjuvant promotes a balanced Th1/Th2/Th17 response independently of IL-12 and IL-17 by acting on Gsα in CD11b⁺ DCsJ Mattsson, K Schön, L Ekman, et al.

Mucosal Immunology|July 13, 2012

Re-utilization of germinal centers in multiple Peyer's patches results in highly synchronized, oligoclonal, and affinity-matured gut IgA responsesP Bergqvist, A Stensson, L Hazanov, et al.

Mucosal Immunology|April 9, 2010

Gene expression profiling identifies STAT3 as a novel pathway for immunomodulation by cholera toxin adjuvantA Sjöblom-Hallén, U Marklund, A Nerstedt, et al.

Pageof 2